Table 3 Relationship between infiltrating growth pattern and other clinicopathological factors
Factors | INFα/β | INFγ | χ2 | P value | |
|---|---|---|---|---|---|
Sex | male | 270 (56) | 212 (44) | 8.49 | <0.01 |
female | 89 (44) | 114 (56) | |||
Site | lower | 240 (53) | 210 (47) | 4.07 | 0.25 |
middle | 40 (45) | 49 (55) | |||
upper | 67 (57) | 51 (43) | |||
entire | 12 (43) | 16 (57) | |||
Age (year) | mean (SD) | 59.6 (9.9) | 56.4 (11.3) | 15.36* | <0.01 |
Size (cm) | mean (SD) | 5.4 (2.2) | 5.6 (2.6) | 0.62* | 0.43 |
Differentiation | well/moderate | 164 (80) | 40 (20) | 91.21 | < 0.01 |
poor | 195 (41) | 286 (59) | |||
Borrmann type | I/II | 65 (60) | 43 (40) | 3.11 | 0.08 |
III/IV | 294 (51) | 283 (49) | |||
Lauren type | intestinal | 162 (80) | 40 (20) | 94.59 | < 0.01 |
mixed | 14 (67) | 7 (33) | |||
diffuse | 183 (40) | 279 (60) | |||
Depth of invasion | dMP | 64 (52) | 59 (48) | 0.01 | 0.93 |
SS | 295 (53) | 267 (47) | |||
Lymphatic/venous invasion | - | 294 (53) | 259 (47) | 0.66 | 0.42 |
+ | 65 (49) | 67 (51) | |||
TNM stage | N0 (0) | 110 (56) | 87 (44) | 9.48 | < 0.05 |
N1 (1–2) | 81 (57) | 60 (43) | |||
N2 (3–6) | 83 (55) | 68 (45) | |||
N3a (7–15) | 59 (42) | 81 (58) | |||
N3b (>15) | 26 (46) | 30 (54) | |||
JCGC stage | N0 | 110 (56) | 87 (44) | 4.66 | 0.20 |
N1 | 116 (56) | 93 (44) | |||
N2 | 119 (48) | 127 (52) | |||
>N3 | 14 (42) | 19 (58) | |||
FCCs # | negative | 55 (56) | 44 (44) | 7.46 | <0.01 |
positive | 3 (19) | 13 (81) |